You have reached the maximum number of Guideline views for today. By creating a free account, you can increase your number of complimentary daily views.
To view this Guideline, please log in to your account. If you do not have an account, you can create one for free by clicking the button below.
Cancer and Contraception
Publication Date: May 1, 2012
Last Updated: March 14, 2022
Recommendations
Combined hormonal contraceptive methods (containing estrogen and progestin) should be avoided by women with active cancer or who have been treated for cancer in the last 6 months due to the increased risk of VTE. (A)